Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-02

Clinical Trial Update: Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing carbetocin to misoprostol for postpartum hemorrhage in placenta previa after cesarean section (update status unknown).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Beni-Suef University | Conditions: Postpartum Hemorrhage | Phase 4 | Status: UNKNOWN